The Challenges Preventing Cancer Cure

The Challenges Preventing Cancer Cure is organized by The British Association for Cancer Research (BACR) and will be held from Mar 10 - 12, 2019 at Francis Crick Institute, London, England, United Kingdom.

Description:
Whilst there is general enthusiasm for recent developments in cancer medicine guided by analysis of an individual cancer patient's genomic alterations (“personalized medicine”) and for the use of immunotherapies for some cancers, there are major questions regarding the efficacy of novel therapies, their cost and whether they significantly impact on the survival of the majority of patients. This conference sets out to address these questions, with presentations both by advocates of current therapeutic approaches and those who consider that different or additional directions are necessary. It lays out the science which underlies the complexity and heterogeneity of advanced cancers and why they are so hard to eradicate.

Presentations will also be made by clinician scientists, leading members of the pharmaceutical industry, healthcare analysts, and medicines agencies. Looking to the future and how early diagnosis may impact to increase survival and “cures”, experts in the liquid biopsy, informatics, telemedicine, and artificial intelligence will address emerging approaches. The program permits ample time for discussion including a concluding forum entitled “Cancer Medicine in 2030 and Beyond – How to Get Ready”. This meeting is unique in composition: its goal is to reflect realistically on the achievements of the cancer research community to date and their limitations and to discuss ways forward to dramatically decrease mortality from cancer in the coming decades.